| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA371733
Max Phase: Preclinical
Molecular Formula: C19H28NO8P
Molecular Weight: 429.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(C)CC(NC(=O)OCc1ccccc1)P(=O)(O)CC(CCC(=O)O)C(=O)O
Standard InChI: InChI=1S/C19H28NO8P/c1-13(2)10-16(20-19(25)28-11-14-6-4-3-5-7-14)29(26,27)12-15(18(23)24)8-9-17(21)22/h3-7,13,15-16H,8-12H2,1-2H3,(H,20,25)(H,21,22)(H,23,24)(H,26,27)
Standard InChI Key: OGPNNUIBMRADRA-UHFFFAOYSA-N
Associated Targets(non-human)
UDP-N-acetylmuramoylalanine--D-glutamate ligase 81 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 429.41 | Molecular Weight (Monoisotopic): 429.1553 | AlogP: 3.12 | #Rotatable Bonds: 12 |
| Polar Surface Area: 150.23 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.54 | CX Basic pKa: | CX LogP: 2.08 | CX LogD: -6.35 |
| Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.37 | Np Likeness Score: 0.23 |
References
| 1. Strancar K, Blanot D, Gobec S.. (2006) Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD., 16 (2): [PMID:16271472] [10.1016/j.bmcl.2005.09.086] |
Source
Source(1):